Gainers

• Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's after-market session. The company's market cap stands at $67.1 million.
• Aardvark Therapeutics (NASDAQ:AARD) stock increased by 19.74% to $4.73. The market value of their outstanding shares is at $85.3 million.
• Geovax Labs (NASDAQ:GOVX) stock moved upwards by 8.13% to $0.23. The market value of their outstanding shares is at $1.1 million.
• NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 7.14% to $1.05. The company's market cap stands at $8.9 million.
• PAVmed (NASDAQ:PAVM) stock rose 6.82% to $2.19. The company's market cap stands at $21.9 million.
• Estrella Immunopharma (NASDAQ:ESLA) shares increased by 6.41% to $0.77. The company's market cap stands at $17.3 million.

Losers

• Scinai Immunotherapeutics (NASDAQ:SCNI) shares decreased by 7.7% to $0.56 during Thursday's after-market session.
• Artiva Biotherapeutics (NASDAQ:ARTV) stock declined by 6.46% to $5.8. The company's market cap stands at $320.7 million.
• Longeveron (NASDAQ:LGVN) shares declined by 6.3% to $1.49. The company's market cap stands at $4.7 million.
• Beyond Air (NASDAQ:XAIR) stock declined by 5.83% to $2.1. The market value of their outstanding shares is at $2.1 million.
• Elicio Therapeutics (NASDAQ:ELTX) stock declined by 5.16% to $1.84. The market value of their outstanding shares is at $41.2 million.
• Valion Bio (NASDAQ:VBIO) stock declined by 4.83% to $0.91. The market value of their outstanding shares is at $1.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.